Because antigens encountered via the enteral route typically elicit immune tolerance, the effects of intranasal and oral insulin on T1D progression have been studied in multiple cohorts of patients with, and at high risk for, T1D. The gene discussed is INS; the disease is type 1 diabetes mellitus.